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A B S T R A C T
Purpose: Resection of the seizure focus leads to sustained seizure-freedom in intractable focal epilepsy in
up to 80% of selected populations. However, surgery fails to help in a considerable proportion of patients.
Reevaluation and reoperation may be considered in a selected group of patients with an unfavorable
postsurgical outcome. Here, we reviewed 15 case series on reoperation after failed resective epilepsy
surgery in adults in order to identify factors associated with a good chance of beneﬁtting from a second
operation.
Methods: Literature review of case series describing the outcome of epilepsy surgical re-operations.
Results: Overall, 3.8–14% of all patients who had resective epilepsy surgery underwent a second operation.
A total of 402 reoperated patients were included. Reoperation was performed in average between 2 and 5.5
years after the ﬁrst surgery. 36.6% of all patients were seizure-free with a minimal follow-up of 6 months to
4 years after the second operation. Postsurgical complications were observed in 13.5% and mainly consisted
of visual ﬁeld defects and, less frequently, of hemiparesis. The causes of failed ﬁrst epilepsy surgery were
heterogeneous and included incorrect localization or incomplete resection of the seizure focus, presence of
additional seizure foci or progression of the underlying disease. Some features appear to indicate successful
reoperation, such as concordance of postsurgical imaging and electroclinical ﬁndings as well as absence of
brain trauma and cerebral infection prior to epilepsy onset.
Conclusion: Reoperation after thorough assessment of all available clinical, imaging and EEG ﬁndings can
be an efﬁcacious and reasonably safe treatment option which can achieve sustained seizure control after
failed resective epilepsy surgery.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
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jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Resective epilepsy surgery can lead to sustained seizure control
in up to 70–80% of selected patients with medically refractory focal
epilepsy.1 This means, in turn, that up to 20–30% of operated
patients will suffer from recurrent seizures after surgery. Epilepsy
surgery is commonly considered as a failure if patients continue to
have disabling seizures (more than ‘‘rarely’’ occurring disabling
seizures, usually classiﬁed as class III and IV according to the Engel
classiﬁcation or outcome class 3–6 according to the ILAE
classiﬁcation).2 People with recurrent postsurgical seizures,
however, may achieve full seizure control later on whether
spontaneously by the ‘‘running down’’ phenomenon,3 by continu-
ation, reinstitution or modiﬁcation of anticonvulsant drugs as well
as by alternative treatment options such as vagal nerve stimulation* Corresponding author at: Department of Epileptology, University Hospital
Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany. Tel.: +49 228 287 14778;
fax: +49 228 287 19351.
E-mail addresses: rainer.surges@gmail.com, rainer.surges@ukb.uni-bonn.de
(R. Surges).
1059-1311/$ – see front matter  2013 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2013.04.020or stimulation of the anterior thalamic nucleus.4–8 Given this
variability in the disease course after a ﬁrst operation, it appears
difﬁcult to deﬁne after how many seizures and after what time
interval following surgery one can assume recurrence of epilepsy.
The situation is further complicated by the sparse knowledge of the
best time point of reevaluation and reoperation, of selection
criteria for appropriate candidates, of potential indicators and
predictors for favorable and unfavorable seizure-outcome after
second surgery, and of efﬁciency and safety of a second surgery.
Taken together, it remains to be elucidated which diagnostic
and therapeutic strategy is appropriate in people after failed
epilepsy surgery. Here, we reviewed pertinent literature and
suggest a practical approach which may allow efﬁcient work-up
and may help in the clinical decision-making when facing people
after surgical failure.
2. Methods
We have considered articles in peer-reviewed scientiﬁc
journals published between January 1980 and January 2013 in
English dealing with reoperation after failed resective epilepsy
surgery in adult patients with medically refractory focal epilepsy.vier Ltd. All rights reserved.
R. Surges, C.E. Elger / Seizure 22 (2013) 493–501494Abstracts and book chapters have not been included in this review.
The following terms were searched on PubMed: reoperation,
second operation, failed epilepsy surgery, focal epilepsy, refractory
epilepsy, and human.
3. Review of the literature
3.1. General characteristics, reevaluation and reoperation rates
Fifteen case series with a total of 402 reoperated patients
fulﬁlled inclusion criteria and were analyzed in this review.
Overall, 3.8–14% of all patients in whom a resective epilepsy
surgery was performed underwent a second operation.9–16 The
time interval between the ﬁrst and second surgical intervention
ranged in average between 2 and 5.5 years (Table 1). Most patients
suffered from temporal lobe epilepsy (TLE) and frontal lobe
epilepsy (FLE) of heterogeneous etiologies as well as hypothalamic
hamartomas in one series (Table 1). Neurosurgical techniques for
the ﬁrst epilepsy surgery varied according to epilepsy type and
underlying pathology (Tables 1 and 2). Following failed resective
epilepsy surgery (commonly reported as class III and IV according
to the Engel classiﬁcation or ILAE classiﬁcation class 3–6), 32–100%
of the patients were reevaluated.9,12,15,17 Of these, 22.1–73.3%
patients proceeded to a second operation,6,9,12,15,17 leading to
reoperation rates between 35.9 and 65.2% in patients with
unfavorable outcome after epilepsy surgery.9,12,15,17 The reasons
for not performing a reoperation included the presence of
inconsistent MRI and EEG ﬁndings, bilateral independent interictal
epileptiform discharges (IED), a widespread seizure focus, overlap
of the seizure focus with eloquent cortex, a compulsory
intracranial study before second surgery (which was considered
difﬁcult or refused by the patient) or simply because the patient
did not want a second surgery.
3.2. Reassessment after failed surgery
A common problem in clinical practice is to deﬁne recurrence of
epilepsy after epilepsy surgery. Occurrence of the ﬁrst and second
postoperative seizure within 6 months after surgery along with an
unprovoked initial recurrence and ipsilateral IED 6 months after
surgery is associated with a poor postsurgical seizure outcome, and
may therefore predict failed epilepsy surgery.18 The decision to
initiate reevaluation, however, is commonly taken on an individual
basis and depends, among other factors, on the actual seizure
control, seizure severity and the patients’ wish. Reassessment
requires a comprehensive review of pre- and postsurgical clinical,
EEG and imaging ﬁndings.
The ﬁrst step usually includes the reappraisal of clinical, MRI
and EEG ﬁndings obtained prior to ﬁrst surgery. A number of
features are associated with the seizure-outcome after a ﬁrst
resective epilepsy surgery, potentially providing explanations for a
failed surgery. For instance, the exclusive presence of ipsilateral
IED, a clear pathology on brain MRI as well as the concordance of
MRI and electroclincial ﬁndings predict a favorable outcome,
whereas the presence of frequent contralateral IED, a normal brain
MRI, disconcordant MRI and electroclinical ﬁndings as well as
frequent secondarily generalized tonic-clonic seizures appear to
predict an unfavorable outcome after a ﬁrst surgery.5,15,19–21
Importantly, the absence of speciﬁc neuropathological ﬁndings of
the resected tissue is also associated with a poorer outcome.22
Altogether, thorough revision of all ﬁndings related to the ﬁrst
surgery may give insights into the causes of insufﬁcient
postsurgical seizure control.
In a second step, postsurgical cerebral MRI is commonly
performed to estimate the quality and extent of the ﬁrst surgical
intervention. In a high proportion of patients after a ﬁrst failedepilepsy surgery, MRI demonstrated residual cerebral structures
including retained mesial, lateral or posterior brain tissue in people
with TLE.9,11,13,15,23,24 It is often challenging to judge whether the
neurosurgical intervention has been performed as intended based
on MRI criteria. When the patient is seizure-free after epilepsy
surgery, the seizure focus has obviously been successfully removed
or the ictogenic network has been sufﬁciently disturbed by
removal of a certain tissue volume. In mesial TLE, this ‘‘critical
mass’’ appears to be rather individual, explaining the wide range of
controversial ﬁndings of various authors and working groups
investigating the optimal extent of resection.25 There is, however,
good evidence that e.g. in the case of selective amygdalohippo-
campectomy, a sufﬁcient technique consists of removal of the
major parts of the uncus and amygdala, the hippocampus and the
parahippocampal gyrus with a posterior extent of about 2.5 cm.26
The clinical value of further imaging studies using single-photon
emission computed tomography (SPECT) or positron emission
tomography (PET) remains to be conﬁrmed, but ﬁrst reports on the
use of e.g. alpha-[11C]methyl-L-tryptophan PET in the reevaluation
after surgical failure are promising.27,28
Finally, video-EEG telemetry with seizure recording is repeated.
To date, it remains to be elucidated after which time interval
following the ﬁrst operation and in whom video-EEG monitoring
should be performed. Jehi and co-workers have addressed these
issues in patients after unsuccessful TLE surgery and found that
seizure recurrence within the ﬁrst postoperative year along with a
‘‘higher’’ seizure frequency (at least 4 seizures per month) predict
successful identiﬁcation of the seizure focus.6 Importantly, in those
patients who displayed seizure recurrence within the ﬁrst 6
months, the seizure focus was distant to the original site of
surgery,6 suggesting that the initial localization of the seizure
generator was wrong or that additional seizure generators were
present. Furthermore, patients with contralateral IED prior to a
standard temporal lobectomy (ﬁrst surgery) were more likely to
have seizure recurrence from the contralateral temporal lobe,
strengthening the importance of thorough reappraisal of all
ﬁndings (see ﬁrst step). In contrast to a standard temporal
lobectomy, people with more limited resections were more likely
to undergo repeat EEG recordings with intracranial electrodes
(Table 2).6 The use of intracranial electrodes was reported in 7.5–
73.3% of the patients before second surgery without increased
complication rates (Tables 1 and 2).9,10,16,23,29 In some of the
patients, intracranial EEG recordings were even performed during
both the ﬁrst and second pre-surgical assessment without
difﬁculties.30
3.3. Success rates and indicators for favorable and unfavorable seizure
outcome after reoperation
The success rates (deﬁned as the proportion of seizure-free
patients) following a second surgery varied considerably between
the published case series and ranged from 9.5 to 57.1%.11,15 Across
all studies, 36.6% of the reoperated patients became seizure-free
(Table 1). This relatively high success rate has to be considered
with caution, because the case series included highly selected
patients who were judged eligible for a second operation with a
good chance of getting seizure free. The criteria for eligibility are
likely to vary from center to center and may include type of
epilepsy and underlying pathology as well as postsurgical MRI
ﬁndings. For instance, it might appear more intuitive to reoperate a
patient with retained mesial structures after a ﬁrst surgery for
mesial TLE with associated hippocampal sclerosis on brain MRI,
than a patient suffering from a non-lesional mesial TLE assessed by
intracranial video-EEG telemetry. It would be helpful to dispose of
speciﬁc features which identify candidates with a good chance of
getting seizure-free after reoperation, but unequivocal predictors
Table 1
Review of case series on reoperation after failed resective epilepsy surgery in adults.
Reference Type of epilepsy
(pathology)
Seizure recurrence
after 1st surgery
No. of re-
operated
and
analyzed
pts.
Favorable seizure
outcome after 2nd
surgery (no. of pts.)a
Complications related to
2nd surgery (no. of pts.)
Minimum
follow-up
after 2nd
surgery
(mean)
Mean time
interval
between 1st
and 2nd
surgery
Indicators/predictors
of favorable seizure
outcome after 2nd
surgery (as highlighted
by the authors)
Indicators/predictors
of unfavorable seizure
outcome after 2nd
surgery (as
highlighted by the
authors)
Siegel et al.16 Mixed (about
two third TLE)
In 89% within the
ﬁrst year
64 I: 22
II: 5
10 pts.:
9 pts. visual ﬁeld defects
1 pt. hemiparesis
1 yr (4.0
yrs)
5.5 yrs Epilepsy duration 5
years prior to ﬁrst
surgery (odds ratio
3.18, 95% CI 1.03,
9.90); focal IEDb prior
to ﬁrst surgery (odds
ratio 4.45, 95% CI 1.22,
16.18)
Gonza´lez-Martı´nez
et al.29
Heterogeneous
population
(FCD, HS,
tumors, dual
pathology,
nonspeciﬁc
lesions)
71% within the ﬁrst
year
57 I: 22
II: 8
12 pts.:
8 pts. quadrantanopsia
4 pts. hemiparesis
2 yrs (10.6
yrs)
4.4 yrs Tumors as initial
pathology better
outcome than FCD or
HS
Germano et al.23 TLE 60% of the patients
within 6 months,
and 90% of the pts.
within the ﬁrst 2
years after surgery
40 I: 21
II: 4
0 pt. 2 yrs (4.8
yrs)
5.5 yrs EEG abnormalities in
multiple brain areas
Salanova et al.14 FLE
(nontumoral)
Not reported 39 1 of 35 seizure-free
6 of 35 seizure-free
after early
postoperative seizures
3 pts.:
1 hemiparesis
1 paresis of leg
1 facial weakness
4 yrs (19
yrs)
Not reported Absence (or signiﬁcant
reduction) of spiking in
ECog after resection
Combined fronto-
temporal resections (in
contrast to frontal
resection alone)
Wyler et al.31 Mixed (mostly
TLE)
Not reported 31 I: 15 3 pts.:
2 pts. quadrantanopsia
1 pt. hemiparesis
Not
reported
Not reported Residual structural
lesions; extension of
the ﬁrst surgery;
invasive EEG
recordings prior to ﬁrst
surgery in non-lesional
epilepsies
Schulz et al.13 Mesial TLE (HS) Not reported 22 I: 9 2 pts.:
1 pt. hemianopia
1 pt. dyslexia/
quadrantanopsia
2 yrs (3.6
yrs)
4.95 yrs Secondary
propagation of ictal
activity to the
contralateral
hemisphere; small
quantity of lateral
temporal lobe
resection
Holmes et al.10 Mixed Not reported 21 I: 9 0 pt. 1 yr (3 yrs) 2 yrs Concordance of
preoperative focal MRI
ﬁndings with ictal EEG
onset before and after
the ﬁrst failed surgery
History of CNS
infection prior to
epilepsy onset
Schwartz and
Spencer46
Heterogeneous
population
(FCD, HS,
tumors, others)
Not reported 21 I: 4 Not reported 1 yr (3.5
yrs)
Not reported Removal of recurrent
tumors, repeated
invasive monitoring to
correct a prior
sampling error
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Table 1 (Continued )
Reference Type of epilepsy
(pathology)
Seizure recurrence
after 1st surgery
No. of re-
operated
and
analyzed
pts.
Favorable seizure
outcome after 2nd
surgery (no. of pts.)a
Complications related to
2nd surgery (no. of pts.)
Minimum
follow-up
after 2nd
surgery
(mean)
Mean time
interval
between 1st
and 2nd
surgery
Indicators/predictors
of favorable seizure
outcome after 2nd
surgery (as highlighted
by the authors)
Indicators/predictors
of unfavorable seizure
outcome after 2nd
surgery (as
highlighted by the
authors)
Salanova
et al.15
TLE Not reported 21 I: 12
II: 5
Not reported 1 yr (range
1–16 yrs)
5.2 yrs Anterior temporal
localization of seizure
focus, abnormal brain
imaging
Pati et al.11 HH Not reported 21 I: 2 12 pts.:
1 pt. symptomatic stroke
5 pts. hyperphagia
1 pt. panhypopituitaris
4 pts. hypernatremia
1 pt. communicating
hydrocephalus
6 months
(median 9
months)
Not reported
Jung et al.17 TLE Immediately after
operation (16 pts.)
17 I: 5 Not reported 1 yr (6.3
yrs)
Not reported History of traumatic
brain injury
Awad et al.9 Mixed
(mostly TLE)
87% within the ﬁrst
6 months
15 I: 7 0 pt. 8 months
(1.5 yrs)
3.2 yrs
Jehi et al.18 TLE 69% within the ﬁrst
year, 31% after the
ﬁrst year
15 I: 6 Not reported Not
reported
Not reported Recurrence of seizures
within the ipsilateral
(to original operation
site) basal and mesial
temporal lobe
Abosch et al.44 Mesial TLE Not reported 13 4 seizure-free Not reported Not
reported
2.6 yrs
Ramos et al.12 Mesial TLE All within the ﬁrst
year
5 I: 2
II: 1
Not reported Not
reported
Not reported
Summary (all) 402 147 seizure-free
(36.6%)
42/310 pts. (13.5%)
Summary
(without HH)
381 145 seizure-free (38%) 30/289 pts. (10.4%)
ECoG: electrocorticography; FCD: focal cortical dysplasia; FLE: frontal lobe epilepsy; HH: hypothalamic hamartoma; HS: hippocampal sclerosis; IED: interictal epileptiform discharges; pts.: patients; SAHE: selective
amygdalohippocampectomy; TLE: temporal lobe epilepsy.
a At last follow-up according to Engel classiﬁcation.
b Opposite to regional, bilateral or generalized IED.
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Table 2
Reassessment and surgical techniques applied in the reviewed case series.
Reference Reassessment
including MRI
and seizure
recording
Invasive extraoperative EEG
recordings prior to 1st
surgery (no. of pts.)
Invasive extraoperative
EEG recordings prior to
2nd surgery (no. of pts.)
Repeated
invasive
recordings
Surgical techniques applied in ﬁrst surgery Surgical techniques applied
in second surgery
Siegel et al.16 Yes 3 pts. 6 pts. Not speciﬁed Lesionectomy (33 pts.), temporal lobe resection (28
pts.), extratemporal resection (3 pts.)
Reoperation was mostly
conﬁned to the same lobe as
ﬁrst operation (55 pts.)
Gonza´lez-Martı´nez
et al.29
Yes 15 pts. 26 pts. 9 pts. Lesionectomy (tumor, FCD), ATL (for mesial TLE, 9
pts.) and SAHE (1 pt.)
Extension of the previous
operation (54 pts.)
Germano et al.23 Yes 6 pts. 3 pts. Not speciﬁed Anterior temporal lobe resections (37 pts.), SAHE (2
pts.), resection of arachnoid cyst (1 pt.)
Extension of ﬁrst operation
(removal of mesiotemporal
structures (amgydala,
hippocampus up to the level
of superior colliculus in 30
pts.)
Salanova et al.14 In some of
the pts.
No No N.A. Electrocorticography-guided resection (26 pts.),
more than one third underwent extensive removal of
frontal lobe including orbital cortex and anterior
cingulate areas
Extension of ﬁrst operation
(26 pts.)
Wyler et al.31 Yes 12 pts. No No Focal resection (31 pts.) Mostly extension of ﬁrst
operation (30 pts.)
Schulz et al.13 Yes 1 pt. No No Keyhole resection of mesiobasal structures after
removal of temporal pole; standard en bloc resection
via the anterior temporal or lateral subtemporal
approach; SAHE via transsylvian or lateral temporal
approach; miminal invasive resection of the
hippocampal formation through a stereotactically
guided working sleeve
Extension of ﬁrst operation
Holmes et al.10 Yes 8 pts. 11 pts. Not speciﬁed Tailored resection (strictly temporal resections 11
pts.; temporal and extratemporal resections 10 pts.)
Mostly extension of ﬁrst
operation (17 pts.)
Schwartz and
Spencer46
Yes 11 pts. 7 pts. 6 pts. No overlap with functional cortex: total removal of
entire ictal onset zone; overlap with functional
cortex: subtotal resection and/or multiple subpial
transsections or stereotactic radiosurgery or total
resection; Mesial temporal sclerosis: standard
anterior medial temporal resection and total
amygdalahippocampectomy;
Extension of ﬁrst operation
(e.g. neocortical resection in
mesial TLE), resection of
recurrent tumors, and others
Salanova et al.15 Yes 9 No No ECoG-guided en-bloc temporal resections or
lesionectomies
ECoG-guided extension of
ﬁrst operation
Pati et al.11 Yes No No N.A. Different techniques (resection via endoscopic,
transcallosal, orbitozygomatic approach,
radiosurgery)
Mostly removal of residual
HH
Jung et al.17 Yes 2 pts. No No SAHE, anterior medial temporal or tailored temporal
lobe resections
Anterior medial temporal (16
pts.), SAHE (1 pt.) on the same
side as ﬁrst surgery
Awad et al.9 Yes Not reported 11 pts. N.A. Temporal or frontal lobectomy (7 pts.), anterior
temporal lobectomy (2 pts), SAHE (2 pts.), topectomy
(2 pts.), anteriomesial temporal lobectomy (1 pt.),
parietal lesionectomy (1 pt.),
Mostly extension of ﬁrst
operation
Jehi et al.18 Yes Not speciﬁed Not speciﬁed Not speciﬁed Standard ATL (dominant: 4–4.5 cm; non-dominant:
5–5.5 cm; hippocampus removed as far back as the
level of superior colliculus) including removal of
mesial structures, temporal tip, parahippocampal
and inferior or temporal gyri) (53 pts.); SAHE
transsylvian or transsulcal, 3 cm hippocampus
resected (5 pts.); lesionectomy (4 pts.); ‘‘tailored’’
resections (6 pts.)
Extension of ﬁrst operation
(basal and mesial parts)
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R. Surges, C.E. Elger / Seizure 22 (2013) 493–501498of favorable seizure outcome after a second surgery have not been
established yet (Table 1). It is tempting to hypothesize that the site
of reoperation and contiguity of the recurrent seizure focus to the
ﬁrst operation site is a relevant predictor of good seizure
outcome.6,31 In most studies, however, the majority of reopera-
tions consisted of a surgical extension of the ﬁrst operation, so that
it is impossible to relate seizure outcome to the site of operation
(Table 1). In one study, tumors as underlying pathology were
associated with a better seizure outcome than focal cortical
dysplasia and hippocampal sclerosis.29 Furthermore, duration of
epilepsy 5 years before ﬁrst surgery and the presence of focal IED
prior to ﬁrst surgery appeared to predict good seizure outcome
after reoperation.16 Potential indicators for unfavorable seizure
outcome after a second surgery include EEG abnormalities in
multiple brain areas, secondary propagation of ictal activity to the
contralateral hemisphere as well as history of encephalitis and
brain trauma before ﬁrst onset of epilepsy (Table 1).10,13,17,23
Interestingly, 4.7–14.1% of the patients who were reoperated
without success were operated a third time and achieved seizure-
freedom in 44.4–100% of the cases.10,16,23,29,32
3.4. Complications related to reoperation
Complication rates related to the second surgery ranged from
0% in reoperated TLE patients to 57.1% in patients reoperated for
hypothalamic hamartoma with an overall complication rate of
13.5% across all studies (42 of 310 patients, Table 1).11,23
Complications mainly included postoperative visual ﬁeld deﬁcits
and less frequently mild to moderate hemiparesis.
4. Discussion
4.1. Limitations of this review and the included studies
This review is based on retrospective case series published from
1989 to 2013, from different epilepsy centers in different countries,
using different imaging and EEG techniques, dealing with very
heterogeneous study populations (e.g. differing localization of the
lesions or operation site as well as variable etiologies such as
hippocampal sclerosis, brain tumor, focal cortical dysplasia,
hypothalamic hamartomas, cavernomas and unspeciﬁc lesions)
being evaluated by many epileptologists and operated and
reoperated by many neurosurgeons with different neurosurgical
techniques. These inherent differences among the cited studies are
mirrored by the high variability of seizure outcomes and illustrate
that it is difﬁcult to draw valid and reliable conclusions on
predictors of successful reevaluation and reoperation after failed
resective epilepsy surgery.
The most important advances in the last decade (and thus the
most important limitations of some of the previous studies) are
probably the development of high resolution MRI and postproces-
sing techniques allowing e.g. the detection of subtle focal cortical
dysplasia or bilateral involvement of mesiotemporal structures
(which have probably not been detected in some of the older
studies because of insufﬁcient, low-resolution imaging techni-
ques) as well as the discovery of novel disease entities such as
autoimmune-mediated epilepsies and the identiﬁcation of genetic
epilepsies which can cause signs of focal epilepsies (e.g. SCN1A
mutations).33–35 Furthermore, the criteria to stratify chances and
risks of epilepsy surgery are likely to vary between tertiary
epilepsy centers, and epileptologists and neurosurgeons from
different centers may request a variable level of consistency of MRI
and electroclinical ﬁndings before proceeding to surgery (e.g. the
decision to operate may be solely based on a MRI-lesion along with
consistent focal IEDs).36 Another important problem is the lack of a
uniﬁed strategy on when and how to taper off anticonvulsant
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of the studies due to differences in the planned discontinuation of
anticonvulsant drugs in seizure-free patients.4 A general problem
is the difﬁculty to determine the actual seizure outcome. Seizure
frequencies are commonly reported by the patients (who may be
unaware of some seizure types or amnesic afterwards, or who do
not report seizures for personal reasons), the relatives and the
caretakers. This method, however, does not provide accurate
seizure counts, and may be biased by seizure types and side of
seizure activity.37 Finally, people may suffer from new onset
psychogenic, non-epileptic seizures after surgery, mimicking
seizure recurrence and failed surgery.38,39
4.2. Pathophysiology and causes of failed epilepsy surgery
Failure of epilepsy surgery has many potential sources.40–42 It
could be due to a wrong initial hypothesis and incorrect
localization of the seizure focus because of disconcordant MRI
and electroclincal ﬁndings or a spatial sampling bias during
intracranial EEG recordings. Seizures may also reoccur because of
a planned limited resection due to contiguity of the seizure focus
to functional cortex or because of an insufﬁcient neurosurgical
technique with a partially retained epileptogenic lesion. For
instance, in people with mesial TLE, residual entorhinal cortex
was found in 9 of 10 patients who did not become seizure-free
after selective amygdalohippocampectomy, as compared to 10
patients who were seizure-free and in whom there was no
evidence of residual entorhinal cortex.24 Seven of the 9 patients
with residual entorhinal cortex were seizure-free after reopera-
tion with resection of the mesiotemporal structures. In one study
assessing causes of failed epilepsy surgery, however, residual
hippocampus was found in 5 patients with mesial TLE, but
thought to be the cause of postsurgical seizure recurrence in one
patient only.43 In another study, there was no signiﬁcant
difference in seizure outcome in mesial TLE patients with or
without residual mesiotemporal structures following selective
amygdalohippocampectomy.44 These results suggest that failed
epilepsy surgery could also be due to inherent properties of more
widespread ictogenic networks. These networks involve e.g. not
only mesiotemporal structures (amygdala, hippocampus, ento-
rhinal cortex and parahippocampal gyrus) in the case of mesial
TLE, but also neocortical or subcortical areas of the ipsilateral
temporal lobe or hemisphere, possibly due to widespread
modiﬁcations caused by recurrent seizure activity, traumatic
brain injury or encephalitis. Some authors have also suggested the
term ‘‘temporal plus epilepsy’’ to describe an entity which
clinically mimics a ‘‘pure’’ TLE, but which involves brain areas in
conjunction with the temporal lobe (such as the orbito-frontal
cortex, the frontal and parietal operculum, the insula and the
temporo-parieto-occipital junction), ultimately leading to incor-
rect or incomplete localization of the seizure focus.45 The
presence of a dual pathology, e.g. hippocampal sclerosis together
with focal cortical dysplasia in the same temporal lobe, has
become frequently apparent with the advent of high resolution
MRI, and is an additional cause of surgical failure.46,47 Finally, the
nature of the underlying disease can lead to a recurrent seizure
focus (e.g. tumor recurrence) or new seizure foci (e.g. involvement
of the contralateral hippocampus in mesial TLE). This may be
partially due to recently described genetic and inﬂammatory
mechanisms such as SCN1A mutations or autoimmune-mediated
limbic encephalitis in association with TLE and hippocampal
sclerosis.33,34 The underlying genetic and inﬂammatory processes
may have not been detected before surgery and could prevent
favorable postsurgical seizure outcome at least in some of the
operated patients. For instance, people with SCN1A mutations
occasionally display hippocampal sclerosis, but commonly sufferfrom generalized or multifocal epilepsies, suggesting that the
sclerotic hippocampus is not the only seizure focus.35,48 More
generally, co-existence of two syndromes such as TLE and
idiopathic generalized epilepsy which has not been detected
before epilepsy surgery or incidental lesions in the context of
symptomatic generalized epilepsies may cause postsurgical
failure. In limbic encephalitis, the more diffuse pathophysiology
with possible affection of both mesiotemporal structures appears
to lower chances of postsurgical seizure-freedom. A selected
group of patients (particularly those with unilateral hippocampal
sclerosis), however, may beneﬁt from resective epilepsy surgery,
as recently suggested.49 It remains to be elucidated whether e.g.
speciﬁc antibodies deﬁne subgroups of patients with limbic
encephalitis which beneﬁt from resective epilepsy surgery in a
disease phase where the underlying inﬂammatory process has
ceased.
4.3. Practical approach to reoperation after failed epilepsy surgery
According to the analyzed case series, the overall chance of
getting seizure-free with a second resective operation amounts to
36.6% with an overall complication rate of 13.5%. This relatively
high success rate is encouraging, but might be not very meaningful
for clinical practice, given the heterogeneous etiologies and
surgical techniques. Thus, these retrospective case series can only
provide some cautious clues to reoperation strategies after failed
epilepsy surgery and general conclusions may not be valid. The
individual medical constellation together with the patient’s desire
to proceed to a second operation should be taken into account
when counseling people after surgical failure. Bearing these
limitations in mind, systematic assessment of the following
features may be helpful to identify those candidates who beneﬁt
most from a second surgery.
4.3.1. History taking and features of postsurgical seizures
* History of encephalitis or traumatic brain injury prior to onset of
epilepsy (may indicate a lower chance of getting seizure free
due to more widespread seizure focus).
* Late onset of epilepsy (may be caused by an autoimmune-
mediated limbic encephalitis, which possibly indicates an
unfavorable outcome).
* Associated learning disabilities (could be due to genetic causes
such as mitochondriopathy or SCN1A mutations which are
potential indicators for an unfavorable outcome).
* Semiology of recurrent seizures (persistence of habitual aura as
a hint that the seizure focus has not completely been removed;
persistence of habitual aura, but novel semiologic aspects after
surgery indicating new propagation pathways; postsurgical
onset of novel initial symptoms suggestive for the development
of a new seizure focus or the activation of a pre-existing, but
inactive seizure focus before surgery; new onset of inhabitual or
bizarre symptoms possibly indicating psychogenic, non-epilep-
tic seizures).
* Time point of seizure recurrence (an early recurrence suggests
that the predominant seizure focus has not been removed, or
that the focus of recurrence is distant to original surgical
bed).6
* Postsurgical seizure frequency (high seizure frequency increases
the likelihood of identifying the seizure focus during repeat
video-EEG telemetry; low seizure frequency may suggest
favorable outcome by additional anticonvulsant drug treatment
or the running-down phenomenon; low frequency, however,
may also indicate a marked and sustained improvement after the
ﬁrst operation and could be an important factor in convincing the
patient and the surgeon to attempt further surgery).3,6
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* EEG abnormalities exclusively ipsilateral to the side of ﬁrst
operation (potential indicator for a favorable outcome).
* Contralateral IED or ictal patterns recorded after surgery
(potential indicator for an unfavorable outcome).
* Secondary propagation of seizure activity to the contralateral
hemisphere e.g. in mesial TLE (potential indicator for an
unfavorable outcome).13
4.3.3. Neuropathology
* Consistency of neuropathological ﬁndings with MRI diagnosis
prior to ﬁrst surgery (e.g. hippocampal sclerosis, focal cortical
dysplasia, benign tumor).
4.3.4. Postsurgical MRI
* Presence of residual and putatively epileptogenic lesions.
* Detection of new lesions (e.g. signs of contralateral hippocam-
pal sclerosis, recurrent brain tumor).
According to the resulting features, individual postsurgical
constellations could be classiﬁed into the following three
categories:
Category I with a good chance of favorable seizure outcome after
reoperation: Patients display consistent electroclinical and MRI
ﬁndings prior to ﬁrst surgery, postsurgical EEG abnormalities
ipsilateral to the side of ﬁrst surgery and residual structures on
postsurgical MRI.
Category II with a moderate chance of favorable seizure outcome
after reoperation: Patients display consistent electroclinical and
cerebral imaging ﬁndings (with a visible lesion on MRI or without a
clear pathology on MRI, but a unilateral regional hypometabolism
in cerebral 18F-ﬂuorodeoxyglucose positron emission tomography
and subsequent conﬁrmative intracranial video-EEG telemetry)
prior to ﬁrst surgery, an apparently sufﬁcient surgery according to
postsurgical MRI and seizure-onset in the same region of or in close
vicinity to the site of the initial operation (e.g. in a patient with
recurrent seizures after a complete selective amygdalohippocam-
pectomy, the second surgery could consist of an extension to the
lateral neocortex or an anterior temporal lobectomy).
Category III with a poor chance of favorable seizure outcome after
reoperation: Patients display inconsistencies of electroclinical and
MRI ﬁndings prior to ﬁrst surgery, a new seizure semiology,
multifocal or widespread EEG abnormalities, an apparently
sufﬁcient surgery according to postsurgical MRI and a seizure-
onset contralateral to the side of the initial operation, novel (or
newly diagnosed) epileptogenic lesions, a limited resection due to
overlap of seizure-focus with eloquent cortex or the postsurgical
diagnosis of underlying genetic or inﬂammatory diseases.
This classiﬁcation is, of course, arbitrary and incomplete, and
thought to provide a practical approach to reoperation strategies.
Patients of category I most likely beneﬁt from a second resective
epilepsy surgery early after recurrence of epilepsy. Patients of
category II may require (repeated) invasive video-EEG telemetry,
additional laboratory investigations (e.g. genetics or determination
of antibodies associated with autoimmune encephalitis) or further
PET- or SPECT-imaging studies. These patients may wait one or two
years after failed surgery to appreciate the natural course
(‘‘running down’’ – phenomenon, efﬁcacy of additional best
medical treatment) before invasive reevaluation and reoperation.
Patients of category III are unlikely to beneﬁt from a reoperation,
and alternative treatments (novel anticonvulsants, vagal nerve
stimulation and stimulation of the anterior thalamic nucleus) may
be considered.In summary, reoperation appears to be an efﬁcacious and
reasonably safe option to achieve sustained seizure control in a
selected group of patients after failed epilepsy surgery. Reevalua-
tion requires thorough assessment of all available clinical, imaging
and EEG ﬁndings in order to identify suitable candidates for
reoperation. The decision to perform reevaluation and reoperation
is individually taken and based on the entire medical constellation
and the patient’s wish.
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